Get startedLog in
    Picture of Centessa Pharmaceuticals logo

    CNTA — Centessa Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Centessa Pharmaceuticals Announces FDA Clearance Of Ind Application For Phase 1/2A Clinical Trial Of Lb101, First Lockbody® Candidate, For Solid Tumors

    Picture of Centessa Pharmaceuticals logoCentessa Pharmaceuticals
    26/01/2023 14:10
    Jan 26 (Reuters) - Centessa Pharmaceuticals PLC
 260y.F :
    * CENTESSA PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND
APPLICATION FOR PHASE 1/2A CLINICAL TRIAL OF LB101, FIRST
LOCKBODY® CANDIDATE, FOR SOLID TUMORS
    * CENTESSA PHARMACEUTICALS PLC - LOOK FORWARD TO INITIATING
PHASE
1/2A TRIAL OF LB101 AS SOON AS POSSIBLE

Source text for Eikon:  ID:nGNX9DkM7J 
Further company coverage:  260y.F 
 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Centessa Pharmaceuticals

    See all news